Received: 14 August 2020
Revised: 1 February 2021
Accepted: 4 March 2021
First Online: 6 May 2021
Compliance with ethical standards
: ML has received research funding and travel support from Janssen-Cilag, study drugs from TEVA, Cheplapharm and Aristopharm, and compensation as a member of the scientific advisory board of Janssen-Cilag and Astex. All the other authors declare no potential competing interests.